Advertisement

Topics

Search Results for "Sjogren A Belimumab"

03:16 EDT 30th August 2016 | BioPortfolio

Matching Channels

None

Matching News

Sjogren's Syndrome Foundation: Rheumatology Clinical Practice Guidelines Published

BETHESDA, MD--(Marketwired - Jul 22, 2016) - As we prepare to celebrate World Sjogren's Day on July 23 rd, the SSF is excited Read more...

New Guidance on Managing Sjogren's Rheumatologic Problems

Sjogren's Syndrome Foundation experts developed new guidelines on rheumatologic manifestations of the disease including fatigue, inflammatory musculoskeletal pain, and use of biologicals. Medscape M...

Diquafosol Sodium in Dry-Eye Patients With Sjogren Syndrome

How does diquafosol sodium compare with artificial tears in terms of increasing aqueous tear volume in Sjogren's syndrome-associated dry eye? Eye

New study links cathepsin S protein to tear secretion in Sjogren's syndrome patients

The autoimmune disorder Sjogren's syndrome is often overlooked or misdiagnosed because the symptoms are similar to other conditions. Its characteristic symptoms are dry eyes and dry mouth, and reduced...

Biomarkers Related to Disease Activity in Sjogren's Syndrome

The authors have identified serum biomarkers that may play a key role in evaluating disease activity in primary Sjogren's syndrome. Arthritis Research & Therapy

Human Genome Sciences and GlaxoSmithKline announce positive Phase 3 study results for Benlysta™ in systemic lupus erythematosus

Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that Benlysta™ (belimumab, formerly LymphoStat-B®) met the primary endpoint in BLISS-52, the first o...

Patients with SLE on baseline steroids may benefit more from belimumab

Patients with systemic lupus erythematosus who received steroids at baseline were more likely to benefit from additional treatment with belimumab vs. patients who did not, according to recently publis...

Comorbid PBC, Sjogren's Raises Risk for Further Complications (CME/CE)

(MedPage Today) -- Overall prognosis worse for those patients

Matching PubMed Articles

A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings.

Belimumab is an approved therapy for the treatment of systemic lupus erythematosus (SLE). This study examined the real-world utilization patterns of belimumab and standard SLE therapies in patients af...

Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study.

Belimumab, a monoclonal anti-B lymphocyte Stimulator (BLyS) antibody, appeared effective in Sjögren's syndrome (SS) in the phase II open-label 52-week BELISS study. Herein, the follow-up after the en...

Secondary Sjogren's Syndrome in 83 Patients With Rheumatoid Arthritis.

Sjogren syndrome (SS) can occur alone, primary Sjogren syndrome, or in association with other rheumatic diseases, secondary Sjogren syndrome (sSS), such as Rheumatoid arthritis (RA). The occurrence of...

Rituximab-refractory lupus nephritis successfully treated with belimumab.

****************************************************************************.

Association Gougerot Sjogren syndrome and celiac disease.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement